Clinical Trial Update: A Phase 3 Study With P2B001 in Subjects With Early Parkinson's [Phase 3]

View source ↗

Summary

Phase 3 trial completed for P2B001 in early Parkinson's disease with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• P2B001

Snippet

Sponsor: Pharma Two B Ltd. | Conditions: Parkinson Disease, Early Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2023-03-21